Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02576743 · ClinicalTrials.gov registry record
Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 90
- Enrollment target
NCT02576743: Completed study, sponsored by University of Minnesota.
NCT02576743 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02576743 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study aims at investigating the blood hemodynamics with high spatiotemporal resolution in patients with brain aneurysms and AVMs as well as in healthy controls. Parameters such as peak blood velocity, wall shear stress and other derived parameters will be obtained from 4D flow MRI data acquired at ultra-high field strength (7 Tesla).
Primary Outcome
Altered brain flow hemodynamics in patients with aneurysms and AVMs compared to normal subjects
Interventions
- DEVICE 7 Tesla MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-09-01 |
What the finished NCT02576743 record still lists
NCT02576743 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 7 Tesla MRI is the first listed.
NCT02576743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02576743 about?
NCT02576743 is a clinical study titled "Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field". This study aims at investigating the blood hemodynamics with high spatiotemporal resolution in patients with brain aneurysms and AVMs as well as in healthy controls. Parameters such as peak blood velocity, wall shear stress and other derived parameters will be obtained from 4D flow MRI data acquired...
What is the current status of trial NCT02576743?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2015-11. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT02576743?
The interventions under investigation include: 7 Tesla MRI (DEVICE).
Who is sponsoring clinical trial NCT02576743?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia